Autologous Cell Therapy Market To Reach Value Of US$ 34.7 Bn By 2027, States TMR Report'

(MENAFN- PR Newswire)

• Rising prevalence of neurodegenerative and autoimmune disorders and cancer is driving the market expansion
• North America is expected to maintain its dominating position in the market owing to presence of sturdy healthcare industry

WILMINGTON, Del., Aug. 15, 2022 /PRNewswire/ -- The market share for autologous cell therapy market is estimated to reach at US$ 34.7 Bn by the end of 2027, according to a research report by Transparency Market Research (TMR).

The autologous cell therapy demand analysis provided by TMR offers 360-degree analysis of the global market. Hence, readers gain access to detailed assessment of the growth drivers, growth restraints, challenges, expansion opportunities, and recent developments in the global autologous cell therapy market . Moreover, the review sheds light on the emerging trends and key market segments in autologous cell therapy.

The autologous cell therapy market in North America is expected to maintain its dominant position during the forecast period. Some of the important factors driving the North America market growth include a rise in the prevalence of several critical health issues, increase in research activities, and the presence of a sturdy healthcare industry in the region.

Get Exclusive PDF Sample Copy of Autologous Cell Therapy Market Report –

Autologous Cell Therapy Market: Key Findings

• Key players in the autologous cell therapy market are increasing R&Ds in order to develop highly effectual products. Such activities are also helping enterprises in new product launches, thereby the expansion of their product portfolios, note analysts at TMR. This aside, players are focusing on key strategies such as regulatory approvals, collaborations, and acquisitions in order to expand their businesses in the global autologous cell therapy market.
• The government authorities of several developed and developing nations globally are taking initiatives in order to provide financial support for different types of research activities focused on the development of effectual treatments on severe diseases. This factor is expected to drive the expansion in the global autologous cell therapy market during the forecast period.
• The American Autoimmune Related Diseases Association (AARDA) notes that there are approximately 50 Mn cases of autoimmune diseases in the U.S. Moreover, prevalence of this diseases is likely to increase in the upcoming years. This factor is creating prominent business opportunities in the global autologous cell therapy market.
• Autologous cell therapy is being increasingly applied in the treatment of different types of diseases including orthopedic, neurological, oncology, and autoimmune disorders. This wide application of the therapy is expected to fuel the expansion opportunities in the global autologous cell therapy market during forecast period.
• The American Cancer Society states that the diagnosis of around 1,762,450 new patients and deaths of approximately 606,880 deaths due to cancer were noted in the U.S. in 2019. Moreover, the Parkinson's Foundation, highlights that presently the population of over 10 million individuals is suffering from the Parkinson's disease (PD). Thus, rising number of such severe health issues is leading to profitable prospects in the global autologous cell therapy market, note analysts of a TMR study.

Ask for References –

Autologous Cell Therapy Market: Growth Boosters

• Increase in the cases of cancer, neurodegenerative disease, and autoimmune disorders globally is boosting the sales growth in the autologous cell therapy market
• Rise in the financial support by government authorities of several nations for research activities is prognosticated to help in the overall market expansion in the near future

Make an Enquiry Before Buying –

Autologous Cell Therapy Market: Key Players

Some of the key players profiled in the report are:

• Castle Creek Biosciences, Inc.
• Pharmicell Co., Inc.
• Lineage Cell Therapeutics, Inc.
• Vericel Corporation
• Caladrius Biosciences, Inc.
• BrainStorm Cell Therapeutics
• Regeneus Ltd.
• Opexa Therapeutics, Inc.
• Sangamo Therapeutics
• Takeda Pharmaceutical Company Limited.
• U.S. Stem Cell, Inc.

Autologous Cell Therapy Market Segmentation

Source

• Bone Marrow (Blood)
• Epidermis
• Others

Application

• Neurology
• Orthopedic
• Cancer
• Wound Healing (including Skin)
• Cardiovascular Disorders
• Autoimmune Disorders
• Others

End-user

• Hospitals
• Ambulatory Centers
• Research Centers

Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

Orthobiologics Market : The global orthobiologics market is anticipated to reach more than US$ 7.4 Bn by the end of 2031 with CAGR of 4.7% from 2022 to 2031.

Atrial Fibrillation Market : The global atrial fibrillation market is anticipated to exceed value of US$ 18.5 Bn by 2031 with a CAGR of 6% from 2022 to 2031.

Ostomy Drainage Bags Market : The global ostomy drainage bags market is expected to cross value of US$ 3.6 Bn by the end of 2031 with a CAGR of 5.4% from 2022 to 2031.

Wound Debridement Market : The wound debridement (wound cleaning) market was valued at US$ 1,964.5 Mn in 2018 and is anticipated to expand at a CAGR of 6.1 % from 2019 to 2027.

Wound Closure Strips Market : The global wound closure strips market was valued at US$ 250 Mn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027.

Advanced Wound Care Management Market : The global advanced wound care management market was valued at US$ 8,531.0 Mn in 2017 and is anticipated to expand at a CAGR of 5.8 % from 2018 to 2026.

Wound Healing Market : The global wound healing market is expected to reach a value of US$35,065.7 mn by the end of 2025. The market is predicted to register a healthy 4.80% CAGR between 2017 and 2025.

Diagnostic Reagents Market : The global diagnostic reagents market is anticipated to reach more than US$ 85.8 Bn by the end of 2031. The global market is projected to grow at a CAGR of 6.5% from 2022 to 2031.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services . Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update -

Contact Rohit Bhisey Transparency Market Research Inc.CORPORATE HEADQUARTER DOWNTOWN,1000 N. West Street,Suite 1200, Wilmington, Delaware 19801 USATel: +1-518-618-1030USA – Canada Toll Free: 866-552-3453 Website :  Blog :  Email: [email protected]

Logo:

SOURCE Transparency Market Research

MENAFN15082022003732001241ID1104697629